Doctor of Podiatric Medicine Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kevin Nguyen

Podiatrist Denver, CO Doctor of Podiatric Medicine

NPI 1316407562 CMS profile 11304955

8101 E Lowry Blvd Ste 230, Denver, CO 80230

Open in the dashboard

General payments

$9,070

53 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kevin Nguyen of Denver, CO is reported in the CMS Open Payments database as having received $9,070 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $145 2
2024 General $1,393 16
2023 General $3,916 23
2022 General $2,415 11
2021 General $1,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Nguyen
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Kevin Nguyen were reported at $145. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Kevin Nguyen Podiatrist median Middle half National median
2019 $0 $196 $72–$601 $163
2020 $0 $118 $38–$335 $114
2021 $1,200 $169 $57–$573 $132
2022 $2,415 $220 $74–$782 $149
2023 $3,916 $208 $71–$635 $160
2024 $1,393 $237 $87–$681 $164
2025 $145 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. CDC Medical LLC $2,407 3 payments
  2. Medline Industries, Inc. $2,043 7 payments
  3. Paragon 28, Inc. $1,768 15 payments
  4. Stryker Corporation $1,483 10 payments
  5. Arthrex, Inc. $367 2 payments
  6. Evolution Surgical, Inc $179 3 payments
  7. Alafair Biosciences,Inc. $149 1 payment
  8. Becton, Dickinson and Company $129 1 payment
  9. Linvatec Corporation $112 1 payment
  10. Checkpoint Surgical, Inc $108 1 payment
  11. Other $326 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $3,910 13 payments
  2. Food and Beverage $2,760 38 payments
  3. Education $2,400 2 payments
Products named General payments · program years 2021–2025
  1. PROSTEP $918 5 payments
  2. PORTFOLIO $877 4 payments
  3. SALVATION $761 3 payments
  4. PROPHECY $713 3 payments
  5. ORTHOLOC 2 LAPIFUSE $713 3 payments
  6. Product Portfolio $538 3 payments
  7. MEDLINE UNITE $350 4 payments
  8. N/A $194 2 payments
  9. VersaWrap $149 1 payment
  10. APEX 3D $143 3 payments
  11. Other $1,461 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Podiatry: 160

Drug cost

$208

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Generic 11 $208

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$21,815

Medicare's payments for the services billed

Medicare patients

100

Average age 75

Services billed

348

64 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Ischemic heart disease 32%
Diabetes 28%
Chronic kidney disease 22%
Osteoporosis 21%
Depression 18%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record